Willem A. Hanekom

25.5k total citations · 2 hit papers
218 papers, 11.0k citations indexed

About

Willem A. Hanekom is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Willem A. Hanekom has authored 218 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Infectious Diseases, 116 papers in Immunology and 84 papers in Epidemiology. Recurrent topics in Willem A. Hanekom's work include Tuberculosis Research and Epidemiology (144 papers), Immunodeficiency and Autoimmune Disorders (68 papers) and Immune responses and vaccinations (53 papers). Willem A. Hanekom is often cited by papers focused on Tuberculosis Research and Epidemiology (144 papers), Immunodeficiency and Autoimmune Disorders (68 papers) and Immune responses and vaccinations (53 papers). Willem A. Hanekom collaborates with scholars based in South Africa, United States and United Kingdom. Willem A. Hanekom's co-authors include Thomas J. Scriba, Mark Hatherill, Gregory Hussey, Hassan Mahomed, Gilla Kaplan, Michèle Tameris, Gerhard Walzl, Sebastian Gelderbloem, Helen McShane and Anthony Hawkridge and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Willem A. Hanekom

213 papers receiving 10.8k citations

Hit Papers

Safety and efficacy of MVA85A, a new tuberculosis vaccine... 2011 2026 2016 2021 2013 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
    2013 753 citations Michèle Tameris, Mark Hatherill et al. profile →
  2. Immunological biomarkers of tuberculosis
    2011 390 citations Gerhard Walzl, Willem A. Hanekom et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Willem A. Hanekom South Africa 60 7.7k 5.7k 5.0k 2.2k 1.5k 218 11.0k
Thomas J. Scriba South Africa 50 5.6k 0.7× 5.2k 0.9× 3.5k 0.7× 1.2k 0.6× 1.9k 1.3× 206 9.2k
Helen McShane United Kingdom 56 7.8k 1.0× 5.6k 1.0× 4.3k 0.9× 1.3k 0.6× 2.0k 1.4× 212 10.7k
W. Henry Boom United States 62 6.9k 0.9× 5.2k 0.9× 5.3k 1.1× 1.7k 0.8× 2.1k 1.5× 213 11.1k
Delia Goletti Italy 61 7.5k 1.0× 2.7k 0.5× 5.3k 1.1× 3.3k 1.5× 1.3k 0.9× 270 10.8k
Gerhard Walzl South Africa 58 7.1k 0.9× 3.0k 0.5× 5.5k 1.1× 3.0k 1.4× 2.0k 1.4× 252 11.0k
Ajit Lalvani United Kingdom 54 8.0k 1.0× 3.5k 0.6× 6.9k 1.4× 4.1k 1.9× 1.3k 0.9× 162 11.8k
David Lewinsohn United States 55 4.5k 0.6× 4.6k 0.8× 4.4k 0.9× 1.6k 0.7× 1.5k 1.1× 151 9.5k
Christoph Lange Germany 52 6.8k 0.9× 1.4k 0.2× 5.7k 1.1× 2.9k 1.3× 1.3k 0.9× 279 9.8k
Gregory Hussey South Africa 43 4.5k 0.6× 2.4k 0.4× 3.5k 0.7× 1.2k 0.6× 662 0.5× 168 7.4k
Marcel A. Behr Canada 57 9.1k 1.2× 3.2k 0.6× 7.8k 1.6× 3.0k 1.4× 2.9k 2.0× 224 12.9k

Countries citing papers authored by Willem A. Hanekom

Since Specialization
Citations

This map shows the geographic impact of Willem A. Hanekom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willem A. Hanekom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willem A. Hanekom more than expected).

Fields of papers citing papers by Willem A. Hanekom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willem A. Hanekom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willem A. Hanekom. The network helps show where Willem A. Hanekom may publish in the future.

Co-authorship network of co-authors of Willem A. Hanekom

This figure shows the co-authorship network connecting the top 25 collaborators of Willem A. Hanekom. A scholar is included among the top collaborators of Willem A. Hanekom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willem A. Hanekom. Willem A. Hanekom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kemp, Steven A., Kimia Kamelian, Diego F. Cuadros, et al.. (2024). HIV transmission dynamics and population-wide drug resistance in rural South Africa. Nature Communications. 15(1). 3644–3644. 8 indexed citations
2.
Rangaka, Molebogeng X., Mike Frick, Gavin Churchyard, et al.. (2023). Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment. The Lancet Respiratory Medicine. 11(4). 380–390. 2 indexed citations
3.
García‐Basteiro, Alberto L., Richard G. White, Dereck Tait, et al.. (2022). End-point definition and trial design to advance tuberculosis vaccine development. European Respiratory Review. 31(164). 220044–220044. 12 indexed citations
4.
Baisley, Kathy, Joanna Orne‐Gliemann, Joseph Larmarange, et al.. (2022). Early HIV treatment and survival over six years of observation in the ANRS 12249 Treatment as Prevention Trial. HIV Medicine. 23(8). 922–928. 6 indexed citations
5.
Penn‐Nicholson, Adam, Thomas Hraha, Ethan Thompson, et al.. (2019). Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study. PLoS Medicine. 16(4). e1002781–e1002781. 68 indexed citations
6.
Misch, Elizabeth Ann, Munyaradzi Musvosvi, Muki Shey, et al.. (2018). Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria. PLoS ONE. 13(12). e0208940–e0208940. 19 indexed citations
7.
Scriba, Thomas J., Chelsea Carpenter, Sebastian Carrasco Pro, et al.. (2017). Differential Recognition of Mycobacterium tuberculosis –Specific Epitopes as a Function of Tuberculosis Disease History. American Journal of Respiratory and Critical Care Medicine. 196(6). 772–781. 36 indexed citations
8.
Shah, Javeed A., Munyaradzi Musvosvi, Muki Shey, et al.. (2017). A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin–Specific Immune Responses and Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 196(4). 502–511. 34 indexed citations
9.
Tebruegge, Marc, Binita Dutta, Susan Donath, et al.. (2015). Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 192(4). 485–499. 82 indexed citations
10.
Andrews, Jason R., Mark Hatherill, Hassan Mahomed, et al.. (2015). The Dynamics of QuantiFERON-TB Gold In-Tube Conversion and Reversion in a Cohort of South African Adolescents. American Journal of Respiratory and Critical Care Medicine. 191(5). 584–591. 94 indexed citations
11.
Machingaidze, Shingai, Suzanne Verver, Humphrey Mulenga, et al.. (2012). Predictive Value of Recent QuantiFERON Conversion for Tuberculosis Disease in Adolescents. American Journal of Respiratory and Critical Care Medicine. 186(10). 1051–1056. 55 indexed citations
12.
Ritz, Nicole, Binita Dutta, Susan Donath, et al.. (2011). The Influence of Bacille Calmette-Guérin Vaccine Strain on the Immune Response against Tuberculosis: A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 185(2). 213–222. 99 indexed citations
13.
Day, Cheryl L., Nazma Mansoor, Marwou de Kock, et al.. (2011). HIV-Specific Gag Responses in Early Infancy Correlate with Clinical Outcome and Inversely with Viral Load. AIDS Research and Human Retroviruses. 27(12). 1311–1316. 4 indexed citations
14.
Kagina, Benjamin M., Bernd Abel, Thomas J. Scriba, et al.. (2010). Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns. American Journal of Respiratory and Critical Care Medicine. 182(8). 1073–1079. 324 indexed citations
15.
Scriba, Thomas J., Brian Eley, Robert J. Wilkinson, et al.. (2010). CD4 and CD8 T-Cell Responses to Mycobacterial Antigens in African Children. American Journal of Respiratory and Critical Care Medicine. 182(1). 120–129. 40 indexed citations
16.
Hatherill, Mark, Tony Hawkridge, Francesca Little, et al.. (2010). Structured Approaches for the Screening and Diagnosis of Childhood Tuberculosis in a High Prevalence Region of South Africa/Approches Structurees Pour le Depistage et le Diagnostic De la Tuberculose Chez L'enfant Dans Une Region d'Afrique Du Sud Ou Cette Maladie Est Fortement prevalente/Sistemas Estructurados De Cribado Y Diagnostico De la Tuberculosis Infantil En Una Region De Alta Prevalencia De Sudafrica. Bulletin of the World Health Organization. 88(4). 312.
17.
Wilkinson, Katalin A., Ronnett Seldon, Graeme Meintjes, et al.. (2009). Dissection of Regenerating T-Cell Responses against Tuberculosis in HIV-infected Adults Sensitized by Mycobacterium tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(7). 674–683. 50 indexed citations
18.
Kalsdorf, Barbara, Thomas J. Scriba, Kathryn J. Wood, et al.. (2009). HIV-1 Infection Impairs the Bronchoalveolar T-Cell Response to Mycobacteria. American Journal of Respiratory and Critical Care Medicine. 180(12). 1262–1270. 115 indexed citations
19.
Cobat, Aurélie, Caroline J. Gallant, Leah Simkin, et al.. (2009). High Heritability of Antimycobacterial Immunity in an Area of Hyperendemicity for Tuberculosis Disease. The Journal of Infectious Diseases. 201(1). 15–19. 49 indexed citations
20.
Hanekom, Willem A., Ellen G. Chadwick, & Ram Yogev. (1995). PNEUMOCOCCAL PAROTITIS IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILD. The Pediatric Infectious Disease Journal. 14(12). 1113–1113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas J. Scriba Breakdown of academic impact, for papers by Helen McShane Breakdown of academic impact, for papers by W. Henry Boom Breakdown of academic impact, for papers by Delia Goletti Breakdown of academic impact, for papers by Gerhard Walzl Breakdown of academic impact, for papers by Ajit Lalvani Breakdown of academic impact, for papers by David Lewinsohn Breakdown of academic impact, for papers by Christoph Lange Breakdown of academic impact, for papers by Gregory Hussey Breakdown of academic impact, for papers by Marcel A. Behr
Rankless by CCL
2026